Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Microdose GLP OneEvidence Edition · Updated July 20, 2026

Medical reviewers

Kim Callender, NP, FNP-BC

Lead Clinical Reviewer

Kim Callender, FNP-BC is a board-certified family nurse practitioner and the lead clinical reviewer for Microdose GLP One. She reviews patient-journey and care-model content: intake quality, prescriber review processes, follow-up access, and support. Her NPI record (1144661760) is listed in the CMS NPPES registry.

Credentials & verification

Kim Callender, NP, FNP-BC — role and verification
RoleLead Clinical Reviewer
Review scopeClinical workflow and patient-care review: provider reviews, care-model comparisons, support testing.
NPI1144661760 — verified in the CMS NPPES registry
VerificationNPI checked against CMS NPPES as of 2026-07-20; the public NPPES taxonomy is the authoritative source for licensure and specialty.

← All reviewers · Publisher: Microdose GLP One. Only confirmed information is shown. Compounded medications are not FDA approved.